UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status No longer recruiting
Unique ID issued by UMIN UMIN000017155
Receipt No. R000019757
Scientific Title Nonrandomized confirmatory study of laparoscopy assisted total gastrectomy and proximal gastrectomy with nodal dissection for clinical stage I gastric cancer (JCOG1401, cSt-I GC LATG PG sP3)
Date of disclosure of the study information 2015/04/17
Last modified on 2017/02/28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Nonrandomized confirmatory study of laparoscopy assisted total gastrectomy and proximal gastrectomy with nodal dissection
for clinical stage I gastric cancer (JCOG1401, cSt-I GC LATG PG sP3)
Acronym Nonrandomized confirmatory study of laparoscopy assisted total gastrectomy and proximal gastrectomy with nodal dissection
for clinical stage I gastric cancer (JCOG1401, cSt-I GC LATG PG sP3)
Scientific Title Nonrandomized confirmatory study of laparoscopy assisted total gastrectomy and proximal gastrectomy with nodal dissection
for clinical stage I gastric cancer (JCOG1401, cSt-I GC LATG PG sP3)
Scientific Title:Acronym Nonrandomized confirmatory study of laparoscopy assisted total gastrectomy and proximal gastrectomy with nodal dissection
for clinical stage I gastric cancer (JCOG1401, cSt-I GC LATG PG sP3)
Region
Japan

Condition
Condition gastric cancer
Classification by specialty
Gastrointestinal surgery
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 To demonstrate the safety of laparoscopy assisted total gastrectomy (LATG) or laparoscopy assisted proximal gastrectomy (LAPG) with nodal dissection for clinical T1N0, T1N+ or T2N0 gastric cancer which is not indicated for EMR/ESD.
Basic objectives2 Safety
Basic objectives -Others
Trial characteristics_1 Confirmatory
Trial characteristics_2
Developmental phase Phase III

Assessment
Primary outcomes Proportion of anastomotic leak
Key secondary outcomes Overall survival, relapse-free survival, proportion of LATG or LAPG completion, proportion of conversion to open surgery, adverse events, and short-term clinical outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 LATG or LAPG with nodal dissection with D1, D1+ or D2 lymph node dissection
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >=
Gender Male and Female
Key inclusion criteria 1) Histologically proven gastric adenocarcinoma.
2) Clinical stage T1N0, T1N(+)*, or T2N0 according to the 14th edition of Japanese Classification of Gastric Carcinoma (3rd English edition).
*T1N(+) corresponds to T1N1 according to the 13th edition of Japanese Classification of Gastric Carcinoma (2nd English edition).
3) In case of T2N0, tumor does not involve greater curvature
4) In case without preceding endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD), either 'cN(+)' or 'cN0 and no indication of EMR or ESD' is eligible.
5) In case with preceding EMR or ESD, the following conditions are all fulfilled:
i) pathological findings require additional gastrectomy
ii) within 91 days from EMR or ESD
iii) no perforation by EMR or ESD
6) R0 resection is expected by total gastrectomy or proximal gastrectomy.
7) No invasion to duodenum or esophagus.
8) Aged 20 to 80 years.
9) PS (ECOG) of 0 or 1.
10) Body mass index less than 30.
11) No history of upper abdominal surgery and no history of intestinal resection except for appendectomy.
12) No prior treatment of chemotherapy or radiation therapy against any other malignancies. History of hormone therapy after more than 1 year from the last administration is eligible.
13) Sufficient organ functions.
i. WBC >= 3,000/mm3
ii. Platelet >= 100,000/mm3
iii. T.Bil =< 2.0 mg/dL
iv. AST =< 100 IU/L
v. ALT =< 100 IU/L
vi. Creatinine =< 1.5 mg/dL
14) Written informed consent.
Key exclusion criteria 1) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or mucosal tumors curatively treated with local therapy.
2) Infectious disease with systemic therapy indicated.
3) Body temperature of 38 or more degrees Celsius.
4) Pregnancy, possible pregnancy, within 28 days after delivery or breast-feeding.
5) Severe psychiatric disease.
6) Continuous systemic steroid or immune-suppressive drug therapy.
7) Unstable angina pectoris, or history of myocardial infarction within six months.
8) Poorly controlled hypertension.
9) Poorly controlled diabetes mellitus in spite of continuous use of insulin.
10) Severe respiratory disease requiring continuous oxygen therapy.
Target sample size 245

Research contact person
Last name of lead principal investigator
1st name
Middle name
Last name Hitoshi Katai
Organization National Cancer Center Hospital
Division name Gastric Surgery Division
Zip code
Address 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, JAPAN
TEL 03-3542-2511
Email hkatai@ncc.go.jp

Public contact
1st name of contact person
1st name
Middle name
Last name Hitoshi Katai
Organization JCOG1401 Coordinating Office
Division name Gastric Surgery Division, National Cancer Center Hospital
Zip code
Address 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, JAPAN
TEL 03-3542-2511
Homepage URL http://www.jcog.jp/
Email JCOG_sir@ml.jcog.jp

Sponsor
Institute Japan Clinical Oncology Group (JCOG)
Institute
Department

Funding Source
Organization Ministry of Health, Labour and Welfare
Organization
Division
Category of Funding Organization
Nationality of Funding Organization Japan

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 函館厚生院函館五稜郭病院(北海道)
恵佑会札幌病院(北海道)
岩手医科大学(岩手県)
山形県立中央病院(山形県)
栃木県立がんセンター(栃木県)
埼玉県立がんセンター(埼玉県)
埼玉医科大学国際医療センター(埼玉県)
国立がん研究センター東病院(千葉県)
千葉県がんセンター(千葉県)
国立がん研究センター中央病院(東京都)
がん・感染症センター都立駒込病院(東京都)
東京医科歯科大学(東京都)
がん研究会有明病院(東京都)
虎の門病院(東京都)
神奈川県立病院機構神奈川県立がんセンター(神奈川県)
横浜市立大学附属市民総合医療センター(神奈川県)
新潟県厚生連長岡中央綜合病院(新潟県)
富山県立中央病院(富山県)
石川県立中央病院(石川県)
岐阜大学医学部(岐阜県)
静岡県立総合病院(静岡県)
静岡県立静岡がんセンター(静岡県)
愛知県がんセンター中央病院(愛知県)
国立病院機構京都医療センター(京都府)
大阪大学医学部(大阪府)
近畿大学医学部(大阪府)
大阪府立病院機構大阪府立成人病センター(大阪府)
国立病院機構大阪医療センター(大阪府)
大阪府立病院機構大阪府立急性期・総合医療センター(大阪府)
市立堺病院(大阪府)
関西医科大学附属枚方病院(大阪府)
大阪労災病院(大阪府)
神戸大学医学部(兵庫県)
関西労災病院(兵庫県)
市立伊丹病院(兵庫県)
天理よろづ相談所病院(奈良県)
和歌山県立医科大学(和歌山県)
岡山大学病院(岡山県)
広島大学病院(広島県)
福山市民病院(広島県)
徳島赤十字病院(徳島県)
大分大学医学部附属病院(大分県)

Other administrative information
Date of disclosure of the study information
2015 Year 04 Month 17 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status No longer recruiting
Date of protocol fixation
2015 Year 02 Month 23 Day
Date of IRB
Anticipated trial start date
2015 Year 04 Month 17 Day
Last follow-up date
2023 Year 04 Month 17 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2015 Year 04 Month 17 Day
Last modified on
2017 Year 02 Month 28 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019757

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.